FDA Import Refusal SCS-2100280-4/11/1 — Bora Pharmaceutical Services Inc.
The FDA refused shipment SCS-2100280-4/11/1 from Bora Pharmaceutical Services Inc. (Canada) on Nov 14, 2018. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 14, 2018
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62GCJ18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75